We found that CD24, PZP, COL1A1, COL1A2, LUM, VCAN, THBS2 and EPHA3 were potential biomarkers for distinguishing NAFLD/NASH. The gene discussed is COL1A2; the disease is metabolic dysfunction-associated steatohepatitis.